What question did this study set out to answer?

The aim is to develop a robust prognostic model that integrates multiple cell-death modalities for melanoma progression and immunity.

July 6, 2026Discover OncologyOpen Access

A machine-learning-derived multi-cell death mode signature predicts melanoma prognosis and reveals an immune-cold tumor microenvironment

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial shows predictive power of a cell death signature in melanoma, indicating immune suppression.

The aim is to develop a robust prognostic model that integrates multiple cell-death modalities for melanoma progression and immunity.
Analyzed transcriptomic and clinical data from TCGA and GEO cohorts.
Constructed a cell death-related signature (CDS) using machine-learning survival pipelines and evaluated its performance.
Assessed tumor microenvironment and immune functional states through advanced statistical analyses.
The CDS reliably stratified melanoma patients into high-risk and low-risk groups with significant predictive accuracy (C-index results).
Higher CDS risk is linked with reduced immune infiltration and increased tumor purity, indicating an immune-cold tumor microenvironment.
MAPK7 was identified as a key gene associated with high risk, correlating with poor outcomes and therapeutically actionable features.

Wu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

July 6, 2026Discover OncologyOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial shows predictive power of a cell death signature in melanoma, indicating immune suppression.

The aim is to develop a robust prognostic model that integrates multiple cell-death modalities for melanoma progression and immunity.
Analyzed transcriptomic and clinical data from TCGA and GEO cohorts.
Constructed a cell death-related signature (CDS) using machine-learning survival pipelines and evaluated its performance.
Assessed tumor microenvironment and immune functional states through advanced statistical analyses.
The CDS reliably stratified melanoma patients into high-risk and low-risk groups with significant predictive accuracy (C-index results).
Higher CDS risk is linked with reduced immune infiltration and increased tumor purity, indicating an immune-cold tumor microenvironment.
MAPK7 was identified as a key gene associated with high risk, correlating with poor outcomes and therapeutically actionable features.

Wu et al. (2026) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark